Summary We examined the ability of primary human tumour cells to secrete diffusible factors capable of stimulating anchorage independent growth of normal rat kidney fibroblast (NRK) cells. Conditioned media (CM) prepared from cells derived from 31/43 patients with adenocarcinoma of the breast, colon, ovary or lung were found to induce growth of NRK cells in soft agar. The ability of the CM to induce anchorage independent growth was enhanced in 25/35 cases by the presence of epidermal growth factor (EGF). The CM did not compete with EGF for binding to the EGF receptor site. CM from cells derived from nonmalignant effusions also supported the growth of NRK cells in soft agar. There was no significant difference in the ability of the CM derived from malignant or normal cells to support NRK colony growth. The ability of primary human tumour cells to clone in soft agar was compared to the ability of these cells to produce diffusible colony stimulating factors for NRK cells. No correlation was observed between the ability of the primary human tumour cells to clone in soft agar and their ability to induce anchorage independent growth of NRK cells. The secretion of substances with TGF like activity may be a property of many types of primary human cells.
Polypeptide growth factors that confer the transformed phenotype on normal cells have been termed transforming growth factors (TGFs) (Sporn and Todaro, 1980) . Recent (Todaro and DeLarco, 1978) . Type ,B TGFs have been found intracellularly in both neoplastic and nonneoplastic murine and human tissues . TGFs ,B are potentiated by EGF and these factors do not compete with EGF for receptor binding. TGFs of this type may play a role in normal cell proliferation as well as neoplastic transformation. The synergistic action of both types of TGF may be required for full expression of the transformed phenotype .
The role of TGF in neoplastic progression in humans is unclear (Nakamura et al., 1983) . Todaro et al. (1980) Preparation of conditioned media (CM) Tumour cells (2 x 106 ml-1) were placed in 100 mm tissue culture dishes in CMRL media containing 2% horse serum, insulin (5 jg ml -1), transferrin (5 jg ml -1) selenium (5 ng ml-1) (Collaborative Research) and soy bean lipids (20 jg ml-1) (Boehringer-Manheim, Indianapolis, IN.). Media was collected 24h after initiation of the cultures, centrifuged at 600g 20 min, and filtered through 0.45 and 0.22 jm filters (Millipore, Bedford, MA. Table I shows the results of experiments in which CM, prepared as described, were used to stimulate anchorage independent growth of NRK cells. Thirty-one of 43 specimens tested secreted factors that stimulated the growth of NRK cells (Table I ). There were no significant differences in the ability of tumour cells derived from different sites to secrete NRK colonystimulating factors (NRK-CSFs) (Wilcoxon two sample test of a 5% probability). CM induced colony growth in only 13/35 cases in the absence of EGF. The number of colonies stimulated by CM in the absence of EGF was low (median 120 range 0-632) ( Table I) . As EGF enhances type I? NRK stimulatory activity, we examined the effect of EGF on the activity of the CM. In 25/35 cases, the effect of CM was potentiated by EGF at 50ngml-'. The addition of EGF gave a 5-20 fold enhancement (median 9.5) of activity. In 2 cases, the colony stimulating activity of the CM was decreased by addition of EGF and in 8 cases there were no significant changes.
The ability of CM to compete with EGF for receptor binding was examined in 43 cases by the method of Roberts et al. (1981) . No EGF receptor ). Therefore, we compared the ability of CM derived from malignant and non-malignant cells to stimulate soft agar growth of NRK cells (Figure 1 ). CM derived from 9/11 non-malignant samples (congestive heart failure, kidney failure) contained NRK-CSF activity. Seven The ability of effusion fluids derived from patients with non-malignant disease to support colony growth was examined (Table II) Figure 2 . Specimens from 27 patients with adenocarcinoma of the breast, colon, ovary or lung were examined. The ability of cells to clone in soft agar varied from patient to patient. The number of colonies for the different tumour types were as follows (median and range): ovary, n=14,332 (0-2000); colon, n=7,25 (0-112); lung, n=2,290 (6-520); breast, n=3,183 (0-256). There was no correlation between the ability of human tumour cells to clone in soft agar at a concentration of 5 x 105 cells ml-1 and their ability to produce TGFs (Figure 2 ).
Discussion
This study demonstrates the common occurrence in human neoplastic and nonneoplastic tissue of substances that stimulate anchorage independent growth of NRK cells. The biological activity of these diffusible substances was similar to that of TGFs previously described (Sporn & Todaro, 1980) . The presence of CSFs in the media may have been due to production of these factors by tumour cells in vitro or release of intracellular substances by dying cells.
In the majority of cases tested, the colony stimulating ability of these substances found in conditioned media was potentiated by the addition EGF. Thus, the activity of these factors most clearly resembles the TGFs described by Roberts et al. (1981) . Whether the EGF induced potentiation was due to enhancement of the activity of different substances already active in the absence of EGF, or to the activity of factors dependent on EGF is not known. However, Nickell et al. (1983) We were unable to find significant differences in the ability of nonneoplastic and neoplastic cells to secrete CSF active either in the absence or presence of EGF. In addition, TGF like activity was found in both nonneoplastic and malignant effusion fluids. This finding is consistent with previous reports indicating TGF activity in nonneoplastic human and murine (Twardzik, et al., 1982) tissues and in human platelets (Assosian, 1983) and sera (Childs et al., 1982) . It is therefore unlikely that simply assaying CM or sera for the presence of TGF-like activity can be used as a screen for malignant potential.
Our work also indicated that the ability of primary human tumour cells to clone in soft agar was unrelated to the ability of these cells to produce substances with NRK colony-stimulating activity. Initial reports had suggested that the ability of human tumour cell lines to clone in agar was related to their ability to produce TGF-like compounds. Similarly, a correlation was found between the ability of SV-40 transformed rat embryo cells to form colonies in agar and their production of TGF-like substances (Kaplan et al., 1981) . Several factors may have accounted for the lack of correlation between the ability of human cells to clone in soft agar and the production of CSFs for NRK cells. First, only crude CM was used in these studies. Inhibitors of anchorage independent growth (Brattain & Levine, 1984) found in acid ethanol extracts of human tumour cell lines, may have been variably present in the CM. Second colony stimulating factors released by tumour cells may be tissue or species specific. A family of TGFlike compounds of differing MW and biological activity has been found in acid ethanol extracts of human tumour cells (Nickell et al., 1983 McClure (1983) found that SV-40 transformed 3T3 fibroblasts could clone in serum-free media only with the addition of CM derived from monolayer high density cultures of 3T3 fibroblasts.
In addition, serum contains factors that contribute to the anchorage independent phenotype (Kaplan et al., 1982) . All primary human tumour clonal assays contain 15% horse sera. Thus, high levels of TGF like activity in sera may have overwhelmed any cellular contribution of TGF like factors. This is borne out by the fact that a linear increase in the number of tumour colonies with increasing numbers of cells plated has been reported (Hamburger & Salmon, 1977) and was consistently seen in this study (data not shown). Such a linear increase would not be expected if the major source of TGF-like compounds was cellularly derived. Attempts to clone primary human tumour cells in serum-free media to more directly test the role of cellular derived TGFs have been unsuccessful (Hamburger et al., 1983) .
Finally, it is possible that TGF-like compounds produced by human tumour cells may not be involved in neoplastic transformation, but have other important growth-promoting activities.
In summary, we have found production of diffusible substances that stimulate anchorage independent growth of NRK cells by a variety of neoplastic and benign primary human cells. The ability of these cells to clone in agar was unrelated to their ability to produce factors that induce anchorage independent growth of NRK cells in vitro. It is likely that these colony stimulating factors play an important role in normal growth and development. Changes in the production and response to such factors could play a role in neoplastic transformation.
